Healthcare AI Acquisition Corp.: debt financing — Healthcare AI Acquisition Corp. borrows $197K from Leading Group; extends $742K in notes

Healthcare AI Acquisition Corp.

New unsecured note for $196,919.23 from Leading Group Limited; $156,474 for extension payment, $40,445 for working capital.
Amendment extends two prior notes ($30,502.20 from May 2025 and $711,619.15 from Aug 2025) to October 14, 2026.
Notes are non-interest bearing, payable in cash upon earliest of business combination, merger termination, liquidation, or October 14, 2026.
Maker is Cayman exempted company; payee is Leading Group Limited, a Cayman exempted company.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Healthcare AI Acquisition Corp. incurred loan of $196,919.23 with Leading Group Limited at The Note does not bear interest maturing payable in cash upon the earlier of (i) consummation of a business combination, (ii) termination of the merger agreement, (iii) liquidation of the Company, or (.

Instrument: loan
Principal: $196,919.23
Counterparty: Leading Group Limited
Rate: The Note does not bear interest
Maturity: payable in cash upon the earlier of (i) consummation of a business combination, (ii) termination of the merger agreement, (iii) liquidation of the Company, or (
Event: incurrence

Exact text from the filing

On May 6, 2026, Healthcare AI Acquisition Corp. (the “Company”) issued an unsecured promissory note (the “Note”) to Leading Group Limited, a Cayman Islands exempted company with limited liability (“Leading Group”), for a loan to the Company in the principal amount of $196,919.23 for extension payments and general working capital purposes.

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Healthcare AI Acquisition Corp. amended loan of $30,502.20 and $711,619.15 with Leading Group Limited at all terms and conditions of the notes remain unchanged maturing payable upon the earliest of (i) consummation of a business combination, (ii) termination of the merger agreement, (iii) liquidation of the Company, or (iv) Oct.

Instrument: loan
Principal: $30,502.20 and $711,619.15
Counterparty: Leading Group Limited
Rate: all terms and conditions of the notes remain unchanged
Maturity: payable upon the earliest of (i) consummation of a business combination, (ii) termination of the merger agreement, (iii) liquidation of the Company, or (iv) Oct
Event: amendment

Exact text from the filing

On May 6, 2026, the Company entered into an amendment (the “Amendment”) to two previously issued unsecured promissory notes, dated May 28, 2025 in the principal amount of $30,502.20 and August 19, 2025 in the principal amount of $711,619.15.

View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR

accession 0001477932-26-002984

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.